Results

Total Results: 2,208 records

Showing results for "drug".

  1. effectivehealthcare-admin.ahrq.gov/products/cervical-ripening/protocol
    May 01, 2020 - Prevention CR Cervical ripening EPC Evidence-based Practice Center FDA Federal Drug
  2. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/hemorrhage-postpartum_disposition-comments.pdf
    April 28, 2015 - Disposition of Comments for CER 151 Management of Postpartum Hemorrhage Comparative Effectiveness Review Disposition of Comments Report Research Review Title: Management of Postpartum Hemorrhage Draft review available for public comment from November 21, 2014 to December 17, 2014. Research Review …
  3. effectivehealthcare-admin.ahrq.gov/sites/default/files/epc-disclosure-policy-form.pdf
    March 01, 2023 - Disclose support ONLY from entities that could be affected financially by the EPC project, such as drug … Disclose support ONLY from entities that could be affected financially by the EPC project, such as drug
  4. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/care-adults-down-syndrome-protocol-amendment.pdf
    February 05, 2025 - or uncertainty).ti,ab. 27 Delivery of Health Care/ or exp Disease Management/ or "Drug-Related … or "disease management" or "drug effects" or "inappropriate prescrib*" or "medical error?"
  5. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/ocr-protocol-final_1.pdf
    December 18, 2019 - Disease Control and Prevention CR Cervical ripening EPC Evidence-based Practice Center FDA Federal Drug
  6. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/meditation_research-protocol.pdf
    October 17, 2012 - Source: www.effectivehealthcare.ahrq.gov Published Online: October 17, 2012 Evidence-based Practice Center Systematic Review Protocol Project Title: Meditation Programs for Stress and Well-Being Amendment Date(s) if applicable: October 10, 2012 (Amendments Details–see Section VII) I. Background Me…
  7. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/cesarean-birth_research.pdf
    January 01, 2020 - Donors in Post Term Pregnancies Conditions: Prolonged Pregnancy; "Nulliparity" Interventions: Drug … : IMN; Drug: Placebo Sponsor: Assistance Publique - Hôpitaux de Paris Study Design: Allocation: … Obese Non-diabetic Pregnant Women Conditions: Pregnancy Complications; Obesity Interventions: Drug … : Metformin; Drug: Placebo Sponsors: Epsom and St Helier University Hospitals NHS Trust; Fetal … Versus Low Dose Oxytocin for Augmentation of Delayed Labour Condition: Birth; Delayed Intervention: Drug
  8. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/colorectal-cancer-screening_disposition-comments.pdf
    February 01, 2012 - While there are fecal occult blood tests that can be purchased over the counter in drug stores and performed … Food and Drug Administration (FDA) and has not obtained FDA clearance or approval. … While there are fecal occult blood tests that can be purchased over the counter in drug stores and … Food and Drug Administration (FDA) and has not obtained FDA clearance or approval.
  9. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/osteoarthritis-knee-update_research-protocol.pdf
    June 15, 2016 - quality of life IADL Independent Activities of daily Living NSAID Non-steroidal anti-inflammatory drug … status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug … including discomfort from osteoarthritis and chronic lower back pain (http://reference.medscape.co m/drug
  10. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/liver-cancer_executive.pdf
    October 01, 2014 - Food and Drug Administration Medical Devices Registration and Listing), and individual product Web … The overall rate of adverse drug-related events was 10%, with all events classified as mild. … Food and Drug Administration approval are ongoing and this technique is commonly used in other areas
  11. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/developing-consistent-useful-quality-improvement.pdf
    September 01, 2020 - suggestion to the medical record, changing the labeling or signage for clarity, and adding or removing a drug … Intensity of the Intervention What is the intensity of the intervention (e.g., dose for drug, duration … patient to intervene, the cost of new equipment, the differential cost of one cleaning solution or one drug
  12. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/methods-binary-outcomes-evaluation_research.pdf
    March 11, 2013 - Only O1 Only O2 ID#* Description ID#* Description K (N) K (N) K (N) 1 Card CD004587 (1)17 Drug-eluting … Major adverse cardiac events by 12 months 15 (6325) 6 (1978) 1 (605) 2 Card CD004587 (1)17 Drug-eluting … Drug-eluting stents versus bare metal stents for angina or acute coronary syndromes.
  13. effectivehealthcare-admin.ahrq.gov/products/methods-balancing-harms-benefits/research-2012
    November 01, 2017 - Skip to main content An official website of the Department of Health & Human Services Careers Contact Us Español FAQs Effective Health Care Program Powered by the Evidence-based Practice Centers …
  14. effectivehealthcare-admin.ahrq.gov/products/documentation-burden/protocol
    September 01, 2023 - Food and Drug Administration, ClinicalTrials.gov, Health Canada, U.K.
  15. Slide 1 (ppt file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/module_i1.ppt
    October 31, 2011 - initial legislation creating the Effective Health Care Program (Section 1013, Medicare Prescription Drug
  16. effectivehealthcare-admin.ahrq.gov/products/acs-pci-adjunctive-devices/research-protocol
    December 01, 2019 - distal protection versus conventional treatment in primary percutaneous coronary intervention: the Drug
  17. Layout 1 (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/rotator-cuff-tear_executive.pdf
    July 01, 2010 - Food and Drug Administration and Health Canada.
  18. effectivehealthcare-admin.ahrq.gov/sites/default/files/presentation.ppt
    August 01, 2009 - This table presents baseline and outcomes data only for the randomized controlled trials of one drug,
  19. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/acs-pci-adjunctive-devices_research-protocol.pdf
    July 01, 2010 - distal protection versus conventional treatment in primary percutaneous coronary intervention: the Drug
  20. effectivehealthcare-admin.ahrq.gov/products/carbohydrate-intake/protocol
    May 01, 2024 - as similar to human milk as possible and is established and strictly regulated by the Federal Food, Drug … J Food Drug Anal. 2021 Mar 15;29(1):1-14. doi: 10.38212/2224-6614.3107. PMID: 35696228.

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: